SCHEMBL3044729

SCHEMBL3044729

CN1CCC(N(C)C(=O)CCn2c(=O)oc3ccccc32)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
CDYL Q9Y232 2/20 0.57
CDY1; CDY1B Q9Y6F8 1/20 0.57
L3MBTL1 Q9Y468 4/20 0.56
POLB P06746 3/20 0.56
MAPK1 P28482 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
RECQL P46063 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
CBX7 O95931 1/20 0.53
CDYL2 Q8N8U2 1/20 0.53
TP53 P04637 1/20 0.53
MAPT P10636 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NPC1 O15118 1/20 0.52
GAA P10253 1/20 0.52
HPGD P15428 1/20 0.52
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8570807 0.81 ALDH1A1 (0.73) ALDH1A1L3MBTL1POLBMAPK1SMN1; SMN2
SCHEMBL13779939 0.76 ALDH1A1 (0.79) ALDH1A1L3MBTL1POLBMAPK1SMN1; SMN2
SCHEMBL23182640 0.74 MAPK1 (0.73) ALDH1A1L3MBTL1POLBMAPK1SMN1; SMN2
Benzene SCHEMBL7861838 0.72 MAPK1 (0.75) ALDH1A1L3MBTL1POLBMAPK1SMN1; SMN2
SCHEMBL2008321 0.72 MAPK1 (0.75) ALDH1A1L3MBTL1POLBMAPK1SMN1; SMN2
SCHEMBL5717757 0.71 MAPK1 (1.00) ALDH1A1L3MBTL1POLBMAPK1SMN1; SMN2
SCHEMBL10443548 0.71 MAPK1 (0.68) ALDH1A1L3MBTL1POLBMAPK1SMN1; SMN2
SCHEMBL8570374 0.71 MAPK1 (0.71) ALDH1A1L3MBTL1POLBMAPK1SMN1; SMN2
SCHEMBL13779980 0.70 ALDH1A1 (0.81) ALDH1A1CDYLCDY1; CDY1BL3MBTL1POLB
SCHEMBL4412650 0.70 HPGD (0.66) ALDH1A1CDYLCDY1; CDY1BMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434765-B1 SUBSTITUTED PIPERIDINES WITH SELECTIVE BINDING TO HISTAMINE H3-RECEPTOR HIGH POINT PHARMACEUTICALS LLC (US) 2009-12-02 EP claimed
US-20100222386-A1 SUBSTITUTED PIPERIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 US disclosed
US-20100222386-A1 SUBSTITUTED PIPERIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 US disclosed
US-20100222386-A1 SUBSTITUTED PIPERIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 US disclosed
US-7767695-B2 Substituted piperidines HIGH POINT PHARMACEUTICALS, LLC (US) 2010-08-03 US disclosed
US-7767695-B2 Substituted piperidines HIGH POINT PHARMACEUTICALS, LLC (US) 2010-08-03 US disclosed
US-7767695-B2 Substituted piperidines HIGH POINT PHARMACEUTICALS, LLC (US) 2010-08-03 US disclosed
EP-1434765-B1 SUBSTITUTED PIPERIDINES WITH SELECTIVE BINDING TO HISTAMINE H3-RECEPTOR HIGH POINT PHARMACEUTICALS LLC (US) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222386-A1 SUBSTITUTED PIPERIDINES HRH3, HRH4, HRH2 ALDH1A1 1285/4885CDYL 3492/4885CDY1; CDY1B 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.